Our in vivo data suggest that MCP-1 is a key target of IL-17A-mediated renal inflammation, as demonstrated by the significant upregulation at gene levels in IL-17A infused mice and by the inhibitory effect of IL-17A blockade in AngII-infused mice. Here, CCL2 is linked to inflammation.